Skip to main content
ConductScienceScienceDex

John Blenis

NIH Rank #1142
Unclaimed recordClaim profile
  • R01 Holder
  • Top 10% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1860024Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology
  • Physiology

NIH Funding · FY2026

Linked Award Amount
$3.5M
Full award amounts, FY2026
Award Records
5
Records listing this PI
Award-Linked Rank
#1,142
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for John Blenis. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing John Blenis as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA046595-39R01
    Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
    Weill Cornell Medicine
    $739.9K
    award amount
  • 5R01CA280572-04R01
    Dissecting the impact of tumor-intrinsic chromosomal instability on the cancer ecosystem
    Weill Cornell Medicine
    $717.8K
    award amount
  • 5R01CA282762-02R01
    A systems-level approach to therapeutically target STING in cancer
    Weill Cornell Medicine
    $701.9K
    award amount
  • 5R01CA301410-31R01
    Signal Transduction to P70 S6 Kinase 1
    Weill Cornell Medicine
    $656.3K
    award amount
  • 5R01CA273357-04R01
    Propionate metabolism and cancer
    Weill Cornell Medicine
    $640.1K
    award amount

Award organization

Organizations that administered FY2026 awards listing John Blenis as a PI.

FY2026 award administered by Weill Cornell Medicine (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4526
  6. 2024
    Entered Top 25% Nationally
    Ranked #4526
  7. 2025
    $5M Cumulative Funding
  8. 2025
    R01 Grant Holder
  9. 2026
    Entered Top 10% Nationally
    Ranked #1142

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as John Blenis.

Ashley Marie Laughney
Weill Cornell Medicine
5
shared awards
Guillermo Burgos-barragan
Weill Cornell Medicine
2
shared awards

Explore further

Find collaborators for John Blenis

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →